Irrespective of the treatment type, compared to the control untreated group, tumors from all drug treated groups exhibited significantly reduced levels of M2‐like TAMs (CD206+) that are associated with pro‐tumor immunosuppressive effects. This evidence concerns the gene MRC1 and neoplasm.